Center for Aquaculture Technologies bolsters leadership with Matt Kramer hire.
The Center for Aquaculture Technologies (CAT) has appointed Matt Kramer as senior vice president of global sales and marketing. He will lead the company’s international rollout of genetic improvement services, with a focus on commercial-scale genome editing for aquaculture.
Kramer has held senior commercial roles at Qiagen, Thermo Fisher, Element Biosciences and Psomagen, with experience across sales, marketing and product management in genomics, molecular diagnostics and next-generation sequencing.
“I was drawn to this role for its combination of strategic scope and purpose — with the opportunity to help shape how genomic and genome-editing technologies transition from research tools into real-world impact. CAT’s culture, scientific and aquaculture industry expertise, and long-term vision align strongly with my own values as a leader. I’m particularly looking forward to bringing the benefits of genome editing into the aquaculture market and delivering responsible, science-based adoption worldwide,” said Kramer.
“Genome editing offers transformative benefits for the global aquaculture industry by enabling targeted genetic improvements that enhance operational productivity, resilience, and sustainability, as complementary methods to traditional selective breeding strategies. My passion has always been to work for companies that drive innovation, and CAT provides exactly that opportunity. As the global population grows, CAT’s genome editing services offer a safe, efficient, and effective way to increase the availability of nutritious food while reducing pressure on wild fish stocks,” he added.
“We are pleased to have Matt join our team. His experience and leadership will be instrumental as we expand the commercialization of genome editing in aquaculture globally. I look forward to introducing him to our clients and am confident that, together with the rest of our team, we will lead CAT into an exciting new era – further driving innovation, boosting productivity and sustainability, and supporting our core mission of feeding people responsibly,” said Dr John Buchanan, CEO of CAT.
